Multiple Sclerosis News Today Forums › Forums › Treating MS › MS Medications › Ocrevus is predicted to be a big moneymaker

  • MS Medications

    Ocrevus is predicted to be a big moneymaker

    Posted by ed-tobias on September 4, 2018 at 6:47 pm

    My MS Wire column, published today, takes a look at the popularity of Ocrevus and how it’s expected to be a big money maker for its developer, Genentech.

    What are your thoughts about the costs of our DMTs? Are they justified, in order to offset the high costs of pharmaceutical development? Can you afford your medications?

    ed-tobias replied 5 years, 8 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .